Clinical trial / 2019
Long-term garlic and vitamin supplementation reduced gastric cancer mortality over 22 years.
During 22 years of follow-up in 3,365 residents, garlic supplementation for 7.3 years significantly reduced gastric cancer mortality (hazard ratio 0.66, 95% CI 0.43 to 1.00), though it did not significantly reduce incidence (odds ratio 0.81, 95% CI 0.57 to 1.13). Vitamin supplementation significantly lowered both gastric cancer mortality (hazard ratio 0.48, 95% CI 0.31 to 0.75) and incidence (odds ratio 0.64, 95% CI 0.46 to 0.91).
- Study type
- Randomized controlled trial
- Who was studied
- 3,365 residents of a high-risk region, China
- What was measured
- Gastric cancer incidence and mortality
THE PAPER
Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial.
Li WQ, Zhang JY, Ma JL, Li ZX, Zhang L, Zhang Y, Guo Y, Zhou T, Li JY, Shen L, Liu WD, Han ZX, Blot WJ, Gail MH, Pan KF, You WC. BMJ, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.